Lv1
92 积分 2024-04-21 加入
A Core Outcome Set for Clinical Trials on Post COVID-19 Condition: “What,” “When,” and “How” to Measure
11天前
已完结
Comparative study on the efficacy and underlying mechanisms of Lonicerae Japonicae Flos and Lonicerae Flos in Shuanghuanglian formula against acute lung injury
1个月前
已完结
Immunomodulatory effect of traditional Chinese medicine in infectious diseases
1个月前
已完结
Nirmatrelvir and molnupiravir maintain potent in vitro and in vivo antiviral activity against circulating SARS-CoV-2 omicron subvariants
1个月前
已完结
Desmoglein-2 modulates tumor progression and osimertinib drug resistance through the EGFR/Src/PAK1 pathway in lung adenocarcinoma
1个月前
已完结
Toward Complex-Systems Evidence for Chinese Medicine: A Four-Phase Evidence Framework
1个月前
已完结
Building on the momentum of N-of-1 base editor therapies for rare diseases
1个月前
已完结
Minimolide F alleviates inflammatory diseases by specifically targeting STING and blocking IRF3 recruitment
1个月前
已完结
Dihydrotanshinone I, a main compound of Salvia miltiorrhiza, alleviates autoimmune and inflammatory diseases by directly targeting IRF3
1个月前
已完结
皖公网安备34019202002308
